Brazilian Red Bourbon (Coffea arabica 'Red Bourbon')

Brazilian Red Bourbon (Coffea arabica 'Red Bourbon') contains trigonelline as its primary bioactive compound, which demonstrates antidiabetic effects through blood glucose reduction. This coffee cultivar also shows potential in cancer therapy by inhibiting Nrf2 gene transcription, making cancer cells more susceptible to programmed cell death.

Origin & History

Brazilian Red Bourbon is a cultivar variant of Coffea arabica L., distinguished by red-colored cherry fruits and cultivated primarily in Brazilian regions like Minas Gerais, particularly the Mantiqueira de Minas area. The coffee is typically processed through wet or semidry methods, with beans roasted at varying temperatures to develop flavor compounds containing chlorogenic acid, trigonelline, and caffeine.

Historical & Cultural Context

The provided research does not contain information about traditional medicine uses of Brazilian Red Bourbon coffee or its historical context in traditional medicine systems. The research focuses solely on modern analytical and cultivation aspects.

Health Benefits

• Antidiabetic effects - Trigonelline component demonstrated blood glucose reduction in animal models (preliminary evidence)
• Potential cancer cell sensitization - Trigonelline functions as Nrf2 gene transcription inhibitor, making pancreatic cancer cells more susceptible to apoptosis (in-vitro evidence only)
• Antioxidant properties - Contains chlorogenic acid, though specific clinical benefits not established in provided research
• Neuroprotective potential - Trigonelline showed beneficial effects in peripheral neuropathy in animal studies (preliminary evidence)
• Note: No human clinical trials specific to Brazilian Red Bourbon were found in the research

How It Works

Trigonelline in Brazilian Red Bourbon coffee acts as an Nrf2 gene transcription inhibitor, disrupting the cellular antioxidant defense pathway in cancer cells. This inhibition makes pancreatic cancer cells more vulnerable to apoptosis by reducing their protective mechanisms. Additionally, trigonelline modulates glucose metabolism pathways, contributing to blood glucose reduction in diabetic conditions.

Scientific Research

The provided research contains no human clinical trials, randomized controlled trials, or meta-analyses specifically evaluating Brazilian Red Bourbon coffee as a therapeutic intervention. Available studies focus on analytical characterization and sensory classification rather than clinical outcomes, with one study examining environmental factors' influence on the related Yellow Bourbon variety's sensory qualities.

Clinical Summary

Current evidence for Brazilian Red Bourbon coffee is primarily from preliminary animal studies and in-vitro research. Animal models demonstrated blood glucose reduction effects from trigonelline components, though specific dosages and sample sizes were not fully established. In-vitro studies showed trigonelline's ability to sensitize pancreatic cancer cells to apoptosis through Nrf2 inhibition. Human clinical trials are needed to confirm these preliminary findings and establish therapeutic dosing protocols.

Nutritional Profile

Brazilian Red Bourbon (Coffea arabica 'Red Bourbon') nutritional composition per standard 240ml brewed cup (using ~10g ground coffee): Macronutrients are negligible - approximately 2-5 kcal, <1g protein, 0g fat, 0g fiber when consumed black. Bioactive compounds are the primary nutritional significance: Caffeine: 80-120mg per 240ml cup (Red Bourbon cultivars trend toward moderate-to-high caffeine density at approximately 1.2-1.4% dry weight of green bean, slightly lower than Typica but variable by altitude and processing); Chlorogenic acids (CGAs): 6-10% of green bean dry weight, predominantly 5-caffeoylquinic acid (5-CQA), with roasting reducing CGA content by 50-80% depending on roast level - light roasts retaining approximately 200-550mg CGAs per cup; Trigonelline: 0.6-1.2% of green bean dry weight (~50-100mg per cup in light roast, degrades significantly under dark roasting to niacin/pyridines); Caffeic acid: trace levels post-brewing (~10-20mg/cup); Niacin (Vitamin B3): generated from trigonelline thermal degradation during roasting, contributing approximately 0.5-2mg per cup. Minerals per 240ml brewed cup: Potassium ~116mg, Magnesium ~7mg, Manganese ~0.1mg, Phosphorus ~7mg. Riboflavin (B2): ~0.18mg per cup. Bioavailability notes: CGAs have 30-33% bioavailability in humans, partially metabolized by colonic microbiota to phenylpropionic acids; caffeine bioavailability approaches 100% via gastrointestinal absorption; trigonelline bioavailability estimated at ~85-90% but is highly roast-dependent. Red Bourbon-specific phenolic profile may show marginally elevated sucrose content (8-9% green bean dry weight vs ~7% in other arabicas), contributing to sweetness and caramelization compounds post-roast, though cultivar-specific CGA subtype ratios lack comprehensive published data distinct from broader arabica datasets.

Preparation & Dosage

No clinically studied dosage ranges for Brazilian Red Bourbon are available in the provided research. The research indicates that processing methods affect bioactive compound concentrations, with semidry processing showing lower levels of chlorogenic acid and trigonelline compared to other methods. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Green tea extract, L-theanine, Rhodiola rosea, Ashwagandha, Alpha-GPC

Safety & Interactions

Brazilian Red Bourbon coffee generally appears safe when consumed in moderate amounts typical of regular coffee intake. However, the caffeine content may interact with stimulant medications and could exacerbate anxiety disorders or sleep disturbances. Individuals taking diabetes medications should monitor blood glucose levels closely due to trigonelline's potential hypoglycemic effects. Pregnant women should limit consumption due to caffeine content, and those with caffeine sensitivity should exercise caution.